Searched over 200M research papers
10 papers analyzed
These studies suggest atenolol can cause skin rash, connective tissue disease, and rare acute psychotic behavior, but generally has fewer central nervous system side effects and effectively reduces blood pressure and anxiety.
20 papers analyzed
Atenolol is a beta-1 selective blocker commonly prescribed for the treatment of hypertension and other cardiovascular conditions. While it is effective in lowering blood pressure and reducing the risk of cardiovascular events, atenolol, like other medications, can have side effects. This article synthesizes research findings on the side effects associated with atenolol, focusing on central nervous system (CNS) effects, dermatological reactions, psychological impacts, and other notable adverse effects.
Atenolol is generally associated with fewer CNS side effects compared to more lipophilic beta-blockers. Studies have shown that atenolol does not significantly affect sleep quality, dreams, concentration, memory, energy, or anxiety levels . However, there are rare instances where atenolol has been linked to acute psychotic behavior, including vivid dreams, nightmares, and short-term memory lapses. These effects are less common due to atenolol's hydrophilic nature, which limits its penetration into the central nervous system .
Research comparing atenolol with methyldopa found that atenolol does not significantly affect reaction time, critical flicker frequency, or subjective feelings of drowsiness, making it less likely to cause sedation or drowsiness compared to other medications.
Atenolol has been reported to induce lupus erythematosus, a rare but serious side effect. Patients may develop psoriasiform skin eruptions, skin necrosis, and vasculitis. In one case, a patient developed lupus erythematosus after three years of atenolol treatment, which resolved upon discontinuation of the drug and reappeared upon rechallenge, confirming the drug's role in the condition.
Atenolol has been shown to reduce arousal significantly over extended periods without affecting anxiety levels. In contrast, acebutolol, another beta-blocker, was found to reduce anxiety but not arousal, highlighting the different psychological effects of these medications.
Studies comparing atenolol with metoprolol have found that atenolol is associated with fewer CNS side effects. Metoprolol, a more lipophilic beta-blocker, has been linked to increased sleep disturbances and restless nights, whereas atenolol did not show significant CNS effects .
In a study comparing atenolol with pindolol, atenolol was found to cause fewer sleep disturbances. Pindolol, due to its higher lipophilicity, was associated with an increase in sleep disturbances, while atenolol actually decreased such issues over time.
Atenolol has been shown to reduce platelet adhesion significantly in hypertensive patients, which may contribute to its cardioprotective effects. However, it has little effect on platelet aggregation and does not significantly alter blood chemistry or hematological parameters.
In a systematic review comparing atenolol with propranolol for the treatment of infantile hemangioma, atenolol was associated with fewer adverse events. Propranolol had a higher incidence of agitation and bronchial hyperreactivity, making atenolol a safer alternative in terms of side effect profile.
Atenolol is an effective beta-blocker with a relatively favorable side effect profile, particularly concerning CNS and psychological effects. While it can cause rare but serious dermatological reactions like drug-induced lupus erythematosus, it generally results in fewer adverse events compared to other beta-blockers such as metoprolol and propranolol. Patients and healthcare providers should weigh these potential side effects against the benefits when considering atenolol for hypertension and other cardiovascular conditions.
Most relevant research papers on this topic